Global Health EDCTP3 Joint Undertaking (EDCTP3)

Awards EUR 50,000 to one scientist recognised for advancing clinical development of products for poverty-related diseases in Africa.

Awards EUR 20,000 to a woman scientist recognised for global-health research and mentorship in sub-Saharan Africa.

Awards EUR 50,000 to a research team recognised for South-North global-health partnerships on poverty-related diseases.

Awards EUR 15,000 to a male mid-career scientist based in the EU or an associated country for global-health leadership.

Awards EUR 15,000 to a male mid-career scientist based in sub-Saharan Africa for global-health leadership.

Awards EUR 15,000 to a woman mid-career scientist based in the EU or an associated country for global-health leadership.

Awards EUR 15,000 to a woman mid-career scientist based in sub-Saharan Africa for global-health leadership.

Funds clinical trials advancing new or improved antimalarial drug combinations toward registration and access in sub-Saharan Africa.

Funds clinical trials of prophylactic vaccines against neglected tropical diseases such as schistosomiasis, leishmaniasis and leprosy in sub-Saharan Africa.

Funds clinical trials of TB vaccine candidates and licensed vaccines targeting adolescents, adults and vulnerable groups in sub-Saharan Africa.

Funds host institutions in sub-Saharan Africa to run Master's fellowships and short courses in epidemiology, biostatistics and infectious-disease modelling, worth up to EUR 90,000 per fellow.

Funds 4 regional research networks in sub-Saharan Africa to run multi-country clinical trials and rapid outbreak-response research.

Funds beyond-proof-of-concept innovations that make infectious-disease prevention, treatment or diagnostics cheaper, more accessible or better suited to sub-Saharan Africa.

Funds late-stage clinical trials of treatments and diagnostics for six climate-linked diarrhoeal disease pathogens in sub-Saharan Africa.

Funds late-stage clinical trials on treating co-infections and co-morbidities in people living with HIV, not HIV itself, across sub-Saharan Africa.

Funds late-stage clinical trials of vaccines, monoclonal antibodies and antivirals against a named list of lower respiratory tract infection pathogens in sub-Saharan Africa.

Funds Phase IIa-and-later clinical trials of new or shorter TB drug and chemoprophylaxis regimens for adults and children in sub-Saharan Africa.

Funds clinical trials or large-scale implementation research on climate-sensitive water- and vector-borne disease control in sub-Saharan Africa and Europe.

Funds coordination projects that scale up validated digital health and AI tools across national or sub-regional health systems in sub-Saharan Africa.

Funds training, twinning and digital-platform networks that raise ethics, regulatory and pharmacovigilance capacity across sub-Saharan African health authorities.